223 related articles for article (PubMed ID: 11299326)
1. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.
Erb C; Troost J; Kopf S; Schmitt U; Löffelholz K; Soreq H; Klein J
J Neurochem; 2001 Apr; 77(2):638-46. PubMed ID: 11299326
[TBL] [Abstract][Full Text] [Related]
2. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
Neurochem Int; 2008 May; 52(6):972-8. PubMed ID: 18023504
[TBL] [Abstract][Full Text] [Related]
3. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
4. Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice.
Stein C; Koch K; Hopfeld J; Lobentanzer S; Lau H; Klein J
Brain Res Bull; 2019 Oct; 152():134-142. PubMed ID: 31323279
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
6. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
[TBL] [Abstract][Full Text] [Related]
7. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
8. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.
Farchi N; Shoham S; Hochner B; Soreq H
Eur J Neurosci; 2007 Jan; 25(1):87-98. PubMed ID: 17241270
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
[TBL] [Abstract][Full Text] [Related]
10. Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.
Farar V; Mohr F; Legrand M; Lamotte d'Incamps B; Cendelin J; Leroy J; Abitbol M; Bernard V; Baud F; Fournet V; Houze P; Klein J; Plaud B; Tuma J; Zimmermann M; Ascher P; Hrabovska A; Myslivecek J; Krejci E
J Neurochem; 2012 Sep; 122(5):1065-80. PubMed ID: 22747514
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional Presynaptic M2 Receptors in the Presence of Chronically High Acetylcholine Levels: Data from the PRiMA Knockout Mouse.
Mohr F; Krejci E; Zimmermann M; Klein J
PLoS One; 2015; 10(10):e0141136. PubMed ID: 26506622
[TBL] [Abstract][Full Text] [Related]
12. No evidence for role of extracellular choline-acetyltransferase in generation of gamma oscillations in rat hippocampal slices in vitro.
Hollnagel JO; Ul Haq R; Behrens CJ; Maslarova A; Mody I; Heinemann U
Neuroscience; 2015 Jan; 284():459-469. PubMed ID: 25453770
[TBL] [Abstract][Full Text] [Related]
13. Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate.
Chang Q; Savage LM; Gold PE
J Neurochem; 2006 May; 97(3):697-706. PubMed ID: 16579834
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
15. Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.
Svedberg MM; Bednar I; Nordberg A
Neuropharmacology; 2004 Sep; 47(4):558-71. PubMed ID: 15380373
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis.
Fujii T; Yoshizawa M; Nakai K; Fujimoto K; Suzuki T; Kawashima K
Brain Res; 1997 Jul; 761(2):244-9. PubMed ID: 9252022
[TBL] [Abstract][Full Text] [Related]
17. Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats.
Giovannini MG; Rakovska A; Benton RS; Pazzagli M; Bianchi L; Pepeu G
Neuroscience; 2001; 106(1):43-53. PubMed ID: 11564415
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice.
Beeri R; Andres C; Lev-Lehman E; Timberg R; Huberman T; Shani M; Soreq H
Curr Biol; 1995 Sep; 5(9):1063-71. PubMed ID: 8542283
[TBL] [Abstract][Full Text] [Related]
19. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
Naik RS; Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
J Pharm Pharm Sci; 2009; 12(1):79-85. PubMed ID: 19470293
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target.
Shaltiel G; Hanan M; Wolf Y; Barbash S; Kovalev E; Shoham S; Soreq H
Brain Struct Funct; 2013 Jan; 218(1):59-72. PubMed ID: 22246100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
